BioMed Central
BioMed Central
BioMed Central (pronounced: /ˈbaɪoʊmɛd ˈsɛntrəl/) is an open access publisher that produces scientific research articles in the field of biomedicine. It was established in the year 2000 and is currently owned by Springer Nature.
Etymology
The term "BioMed Central" is derived from the combination of "BioMed", an abbreviation for "biomedical", and "Central", indicating its role as a central hub for biomedical research.
History
BioMed Central was founded in 2000 by Vitek Tracz, a pioneer in the field of open access publishing. In 2008, it was acquired by Springer Science+Business Media, which later merged with Holtzbrinck Publishing Group to form Springer Nature in 2015.
Operations
BioMed Central operates on an open access model, which means that all its published research is freely available online for anyone to read, use, and distribute. It covers a wide range of disciplines within biomedicine, including biology, medicine, and public health. The publisher currently hosts over 290 peer-reviewed journals.
Related Terms
- Open Access: A publishing model that allows unrestricted access to research articles online.
- Springer Nature: A global publisher specializing in academic, educational, and professional content.
- Biomedicine: A branch of medical science that applies biological and physiological principles to clinical practice.
- Peer Review: The evaluation of work by one or more people with similar competences as the producers of the work.
External links
- Medical encyclopedia article on BioMed Central
- Wikipedia's article - BioMed Central
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski